Safety Study of Melatonin in Stroke Patients
NCT01863277 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 140
Last updated 2013-05-27
Summary
The purpose of the study is to evaluate the effect of Melatonin (in a dosage of 14mg daily) for a better clinical outcome in the period three days post stroke.
Conditions
- Acute Ischemic Stroke
Interventions
- DRUG
-
Melatonin
- DRUG
Sponsors & Collaborators
-
Wolfson Medical Center
lead OTHER_GOV
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2014-04-30
Countries
- Israel
Study Locations
More Related Trials
-
Relationship of Nocturnal Concentrations of Melatonin, γ-aminobutyric Acid and Total Antioxidants With Insomnia
NCT03202121 ·Status: UNKNOWN
-
Efficacy and Safety of Jiedu Tongluo Granules for Post-stroke Depression
NCT03147053 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Safety and Effective Study of Ginkgolides Diterpene Lactone Meglumine Injection in the Treatment of Ischemic Stroke.
NCT02526225 ·Status: COMPLETED ·Phase: PHASE2
-
TRPM8 in Acute Ischemic Stroke by Topical Menthol
NCT05877079 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke
NCT06861426 ·Status: NOT_YET_RECRUITING
-
Efficacy Study of Huatuo Zaizao Pills in Improving of Neural Function in Acute Ischemic Stroke
NCT01758536 ·Status: UNKNOWN ·Phase: PHASE4
-
Intracerebral Transplantation of Neural Stem Cells for the Treatment of Ischemic Stroke
NCT03296618 ·Status: UNKNOWN ·Phase: PHASE1
-
Qingre Huatan Formula for the Prevention of Early Neurological Deterioration in Acute Ischemic Stroke
NCT06857487 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
The Effect of Trazodone on the Severity of Obstructive Sleep Apnea in Insomnic Stroke Patients With Depression
NCT04162743 ·Status: COMPLETED ·Phase: PHASE4
-
Study on the Clinical Efficacy of Chinese Medicine Treatment of Sequelae of Apoplexy
NCT03077984 ·Status: UNKNOWN ·Phase: NA
-
Post-stroke Depression Treatment Effect on Stroke Recurrence
NCT04776226 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of Shengdi Dahuang Decoction in the Treatment of Acute Hemorrhagic Stroke
NCT04200781 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke
NCT04415164 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Plan of Ischemic Stroke
NCT04953663 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Tongxinluo Capsule in Ischemic Stroke Patients（TISS)
NCT01919671 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Study of iNSC Intervent Cerebral Hemorrhagic Stroke
NCT03725865 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Effects of Intravascular Laser Irradiation of Blood for Mitochondral Dysfunction in Cerebral Ischemic Stroke
NCT06932627 ·Status: COMPLETED ·Phase: NA
-
Non-disabling Ischemic Cerebrovascular Event With Apathy
NCT04917237 ·Status: RECRUITING
-
Clinical Study to Investigate the Safety and Efficacy of MLC601 in 150 Iranian Patients After Stroke
NCT01336153 ·Status: COMPLETED ·Phase: PHASE4
-
Ozone Autohemotherapy for Ischemic Stroke Sleep Disorder
NCT05508113 ·Status: UNKNOWN ·Phase: NA
-
Cognitive Impact of Pomegranate Polyphenols Following Ischemic Stroke
NCT02442804 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness and Safety of Angongniuhuang Pill on Restoring Consciousness for Patients Who Have Suffered From a Stroke
NCT00817609 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
NEURoaid II (MLC 901) Assessment in Cognitively Impaired Not Demented Subjects
NCT01847924 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness and Safety of Rhubarb for the Treatment of Patients Who Have Suffered From a Stroke
NCT00789269 ·Status: UNKNOWN ·Phase: PHASE2
-
Randomized Controlled Trial of Time-Restricted Feeding (TRF) in Acute Ischemic Stroke Patients
NCT04184076 ·Status: UNKNOWN ·Phase: NA